What is the dosage and treatment protocol for Amoxyclave (amoxicillin and clavulanic acid) 625?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dosage and Treatment Protocol for Amoxiclave 625 (Amoxicillin and Clavulanic Acid)

The standard dosage for Amoxiclave 625 in adults is one tablet (500 mg amoxicillin/125 mg clavulanic acid) three times daily for 14 days for most respiratory infections. 1, 2

Adult Dosing Guidelines

  • For adults with mild to moderate infections, the standard dose is 500 mg amoxicillin/125 mg clavulanic acid (one tablet of Amoxiclave 625) every 8 hours (three times daily) for 7-14 days, depending on the infection type 2, 3
  • For respiratory infections caused by resistant pathogens or in patients with risk factors, a higher dose may be required 2
  • Treatment duration varies by condition but is typically 14 days for bronchiectasis and respiratory infections 1
  • A twice-daily regimen (875/125 mg) can be as effective as the three-times-daily regimen for lower respiratory tract infections, with potentially fewer gastrointestinal side effects 4

Specific Indications and Dosing

Respiratory Infections

  • For bronchiectasis exacerbations with beta-lactamase producing Haemophilus influenzae: 625 mg three times daily for 14 days 1
  • For bronchiectasis exacerbations with Moraxella catarrhalis: 625 mg three times daily for 14 days 1
  • For acute bacterial sinusitis in adults with risk factors (recent antibiotic use, treatment failure): 625 mg three times daily for 5-7 days 1, 2

Risk Factors Requiring Amoxiclave Instead of Amoxicillin Alone

  • Recent antibiotic use (past 4-6 weeks) 1, 2
  • Beta-lactamase producing pathogens suspected 5
  • Failed previous therapy with amoxicillin alone 2
  • Moderate to severe infections 2
  • Immunocompromised status 2
  • Age over 65 years 2

Pediatric Dosing

  • For children with uncomplicated infections: 45 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanic acid divided into 2 doses 2
  • For children with risk factors or more severe infections: 80-90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanic acid divided into 2 doses 1, 2
  • For non-severe childhood pneumonia where amoxicillin has failed: high-dose amoxicillin-clavulanic acid (80-90 mg/kg/day amoxicillin component) for 5 days 1

Important Clinical Considerations

  • The clavulanic acid component limits the maximum daily dose due to potential gastrointestinal side effects 6
  • Amoxicillin-clavulanic acid should be used instead of amoxicillin alone when beta-lactamase producing organisms are suspected 5
  • Common side effects include diarrhea and gastrointestinal disturbances; taking with food can reduce these effects 6, 3
  • Clinical studies have shown that amoxicillin-clavulanic acid is more effective than amoxicillin alone for post-surgical oral interventions, with significantly reduced pain and swelling 3

Special Populations

  • For patients with renal impairment, dose adjustment may be necessary 6
  • For elderly patients, standard adult dosing is typically appropriate, but monitoring for adverse effects is recommended 2

Antimicrobial Spectrum

  • Amoxicillin-clavulanic acid maintains the activity of amoxicillin against Streptococcus pneumoniae while extending coverage to beta-lactamase producing organisms 5
  • Particularly effective against Haemophilus influenzae (95-100%) and Moraxella catarrhalis (100%) 5
  • Also effective against beta-lactamase producing Staphylococcus aureus (MSSA) 1

Common Pitfalls and Caveats

  • Overuse of amoxicillin-clavulanic acid when amoxicillin alone would suffice can contribute to antimicrobial resistance 7
  • The clavulanic acid component is associated with more gastrointestinal side effects than amoxicillin alone 6
  • Multiple formulations with different amoxicillin-to-clavulanic acid ratios exist globally, which can lead to confusion in dosing 7
  • Always verify that the infection is bacterial before prescribing, as viral infections will not respond to antibiotics 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amoxicilina-Ácido Clavulánico Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Amoxicilina y Amoxicilina-Clavulánico

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral amoxicillin and amoxicillin-clavulanic acid: properties, indications and usage.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.